The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000277.2(PAH):c.770G>T (p.Gly257Val)

CA229753

102830 (ClinVar)

Gene: PAH
Condition: phenylketonuria
Inheritance Mode: Autosomal recessive inheritance
UUID: 86128709-27f5-48f5-93a6-695080b882ef
Approved on: 2020-11-14
Published on: 2022-03-11

HGVS expressions

NM_000277.2:c.770G>T
NM_000277.2(PAH):c.770G>T (p.Gly257Val)
NC_000012.12:g.102852887C>A
CM000674.2:g.102852887C>A
NC_000012.11:g.103246665C>A
CM000674.1:g.103246665C>A
NC_000012.10:g.101770795C>A
NG_008690.1:g.69716G>T
NG_008690.2:g.110524G>T
ENST00000553106.6:c.770G>T
ENST00000307000.7:c.755G>T
ENST00000549247.6:n.529G>T
ENST00000553106.5:c.770G>T
NM_000277.1:c.770G>T
NM_001354304.1:c.770G>T
NM_000277.3:c.770G>T
NM_001354304.2:c.770G>T
NM_000277.3(PAH):c.770G>T (p.Gly257Val)
More

Pathogenic

Met criteria codes 4
PP4_Moderate PM2 PM3_Very Strong PP3
Not Met criteria codes 2
PS3 PM5

Evidence Links 3

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
The c.770G>T (p.Gly257Val) variant in PAH has been reported in multiple individuals with PAH deficiency (BH4 deficiency excluded) (PMID: 26503515). This variant is absent in population databases. This variant was detected with multiple pathogenic variants: p.R408Q, p.Ser70del (PMID: 26322415); p.R111X (PMID: 14722928); p.Arg261Gln (PMID: 17502162); c.1068C>A (p.Y356*, PMID: 25894915); p.Arg252Trp, p.Arg243Gln, p.His107Arg, p.Leu255Ser (PMID: 28982351). Computational prediction tools and conservation analysis support a deleterious effect. In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM3_very-strong, PM2, PP4_Moderate, PP3.
Met criteria codes
PP4_Moderate
G257V identified in on at least 11 PKU alleles, plasma phenylalanine (Phe) levels, dihydropteridine reductase activity, urinary biopterin and neopterin ratio, and tetrahydrobiopterin loading, were collected. PMID: 26503515

PM2
Absent from ExAC, gnomAD, 1000G, ESP
PM3_Very Strong
Detected with R408Q (P), p.Ser70del (P-3 submitters) All mutations identified in patients were confirmed by analyzing parental DNA PMID: 26322415; R111X (P-7 submitters) parental analysis not reported PMID: 14722928; p.Arg261Gln (P-11 submitters), parental analysis not reported PMID: 17502162; .1068C>A (p.Y356* P-7 submitters) parental analysis not reported PMID: 25894915; p.Arg252Trp (P), p.Arg243Gln (P), S70del, p.His107Arg (P/LP), p.Tyr356*, p.Leu255Ser (P/LP). variable sites in patient genes were aligned with the corresponding sites from the respective parents. PMID: 28982351 9.0 pts

PP3
Predicted deleterious in SIFT, Polyphen2, MutationTaster. REVEL=0.991
Not Met criteria codes
PS3
In vitro enzyme activity of 1% of wt PMID: 24401910
PM5
3 other variants in this codon, no clinical assertion in ClinVar
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.